Sunday, 25 August 2019

Japan News

  • Daiichi Sankyo, Ranbaxy to leverage synergies in Thailand

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2013

    Singapore: Japan's Daiichi Sankyo and Ranbaxy Laboratories have plans to integrate their business operations in Thailand, to leverage and maximize the synergies of the Hybrid Business Model...Read more

  • RIKEN's new chip detects traces of miRNA in only 20 mins

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 09 Nov, 2012

    Singapore: A new power-free microfluidic chip developed by researchers at the RIKEN Advanced Science Institute, Japan, has enabled the detection of microRNA from extremely small sample vol...Read more

  • Hoya appoints new executive officer

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 26 May, 2014

    Singapore: Japan based Hoya Corporation has appointed Mr Augustine Yee as its executive officer, chief legal officer and head of corporate development and affairs. As the company's first c...Read more

  • Takeda's center among Chicago's top 100 workplaces

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 14 Nov, 2012

    Singapore: Takeda Pharmaceuticals' Deerfield campus has been listed among Chicago's top 100 workplaces by the Chicago Tribune. The list of the best places to work in the Chicago area is ba...Read more

  • Eisai launches beauty drink in Japan

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 26 Feb, 2013

    Singapore: Japan-based Eisai is going to launch its new carbonated supplement drink named 'Chocola BB Sparkling + Fiber'. The drink will contain Niacin and would be available at convenience...Read more

  • Eisai seeks nod for Helicobacter Pylori treatment

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 01 Jun, 2012

    Singapore: Eisai, which has its headquarters in Tokyo, has submitted a marketing authorization application to Japan's Ministry of Health, Labor and Welfare for approval of two types of new ...Read more

  • Will Keryx's ferric citrate NDA get nod in Japan?

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 08 Jan, 2013

    Singapore: Keryx Biopharmaceuticals announced that its Japanese partner, Japan Tobacco (JT), has filed a New Drug Application (NDA) with the Japanese Ministry of Health, Labour and Welfare...Read more

  • FDA accepts sNDA for Astellas cancer drug

    Japan |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 17 Jan, 2013

    Singapore: The US FDA has accepted Astellas Pharma's US subsidiary filing of a supplemental New Drug Application (sNDA) for Tarceva (erlotinib) for first-line use in people with locally adv...Read more

  • EMA to review marketing plea for antipsychotic medication

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 29 Oct, 2012

    Singapore: The European Medicines Agency (EMA) has accepted the marketing authorization application for review of an atypical antipsychotic medication lurasidone hydrochloride. The product ...Read more

  • Ranbaxy advisory: All our products are safe and efficacious

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 03 Jun, 2013

    New Delhi: Ranbaxy issued an advisory claiming that all their products in the Indian and global markets are safe and efficacious. The firm revealed that the advisory was issued in public i...Read more

  • Amgen to acquire Onyx for $10 bn cash

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 26 Aug, 2013

    Singapore: Global biopharmaceutical company Amgen plans to acquire all the outstanding shares of Onyx Pharmaceuticals for $125-per-share, totalling to $10.40 billion, in cash. The deal woul...Read more

  • Effient trial by Daiichi, Lilly fails to meet primary endpoint

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 27 Aug, 2012

    Singapore: The TRILOGY ACS study, a phase III trial comparing prasugrel plus aspirin to clopidogrel plus aspirin in patients with unstable angina (UA) or non-ST elevation myocardial infarct...Read more

  • Takeda ends 3-year-old-deal with Amylin

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 26 Dec, 2012

    Singapore: Takeda Pharmaceutical mutually terminated its worldwide agreement with Amylin Pharmaceuticals, which was originally signed in October 2009, to co-develop and commercialize compo...Read more

  • EMA committee positive on Teduglutide

    Japan |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 25 Jun, 2012

    Singapore: The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has adopted a positive opinion for the medicinal product teduglutide (tradename in Euro...Read more

  • Astellas Pharma opens office in Singapore

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 12 Dec, 2013

    Singapore: Astellas Pharma, Japan's pharmaceutical giant with net sales of $10.7 billion and net income of $881 million as at March 31, 2013, has opened its office in Singapore. Astellas w...Read more

  • Sucampo gets $15 mn payment from Abbott

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 12 Dec, 2012

    Singapore: Sucampo Pharmaceuticals' subsidiary SPL has received a $15 million milestone payment from Abbott's subsidiary, Abbott Japan, pursuant to the existing license, commercialization ...Read more

  • Scotland approves Eisai's Fycompa

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2013

    Singapore: Eisai announched that Scotland's health technology assessment (HTA) body, the Scottish Medicines Consortium (SMC), has approved Eisai's AMPA receptor antagonist Fycompa (perampa...Read more

  • Zoll establishes Japanese subsidiary

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 29 Oct, 2012

    Singapore: ZOLL Medical, a manufacturer of medical devices and related software solutions and a wholly owned US subsidiary of Asahi Kasei, has established Asahi Kasei ZOLL Medical Corporat...Read more



Podcast

 

Survey Box

Will APAC lead the way for innovation in the field of precision medicine?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls